Cargando…

SARS-CoV-2 triggering autoimmune diseases

Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, byst...

Descripción completa

Detalles Bibliográficos
Autores principales: Mobasheri, Leila, Nasirpour, Mohammad Hossein, Masoumi, Elham, Azarnaminy, Afsaneh Foolady, Jafari, Mozhdeh, Esmaeili, Seyed-Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979824/
https://www.ncbi.nlm.nih.gov/pubmed/35461172
http://dx.doi.org/10.1016/j.cyto.2022.155873
_version_ 1784681261918322688
author Mobasheri, Leila
Nasirpour, Mohammad Hossein
Masoumi, Elham
Azarnaminy, Afsaneh Foolady
Jafari, Mozhdeh
Esmaeili, Seyed-Alireza
author_facet Mobasheri, Leila
Nasirpour, Mohammad Hossein
Masoumi, Elham
Azarnaminy, Afsaneh Foolady
Jafari, Mozhdeh
Esmaeili, Seyed-Alireza
author_sort Mobasheri, Leila
collection PubMed
description Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as “cytokine storm,” and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease.
format Online
Article
Text
id pubmed-8979824
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89798242022-04-05 SARS-CoV-2 triggering autoimmune diseases Mobasheri, Leila Nasirpour, Mohammad Hossein Masoumi, Elham Azarnaminy, Afsaneh Foolady Jafari, Mozhdeh Esmaeili, Seyed-Alireza Cytokine Article Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as “cytokine storm,” and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease. Elsevier Ltd. 2022-06 2022-04-05 /pmc/articles/PMC8979824/ /pubmed/35461172 http://dx.doi.org/10.1016/j.cyto.2022.155873 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mobasheri, Leila
Nasirpour, Mohammad Hossein
Masoumi, Elham
Azarnaminy, Afsaneh Foolady
Jafari, Mozhdeh
Esmaeili, Seyed-Alireza
SARS-CoV-2 triggering autoimmune diseases
title SARS-CoV-2 triggering autoimmune diseases
title_full SARS-CoV-2 triggering autoimmune diseases
title_fullStr SARS-CoV-2 triggering autoimmune diseases
title_full_unstemmed SARS-CoV-2 triggering autoimmune diseases
title_short SARS-CoV-2 triggering autoimmune diseases
title_sort sars-cov-2 triggering autoimmune diseases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979824/
https://www.ncbi.nlm.nih.gov/pubmed/35461172
http://dx.doi.org/10.1016/j.cyto.2022.155873
work_keys_str_mv AT mobasherileila sarscov2triggeringautoimmunediseases
AT nasirpourmohammadhossein sarscov2triggeringautoimmunediseases
AT masoumielham sarscov2triggeringautoimmunediseases
AT azarnaminyafsanehfoolady sarscov2triggeringautoimmunediseases
AT jafarimozhdeh sarscov2triggeringautoimmunediseases
AT esmaeiliseyedalireza sarscov2triggeringautoimmunediseases